Monocytosis

Monocytosis is an elevation of circulating monocytes, a type of white blood cell derived from the myeloid lineage. In adults, it is typically defined as an absolute monocyte count above 0.8 x 10^9/L or more than 8% of total leukocytes on a complete blood count.

Causes and associations: Infections such as chronic tuberculosis, fungal infections, and other intracellular pathogens; inflammatory and autoimmune disorders (for example inflammatory bowel disease, sarcoidosis, systemic lupus erythematosus, rheumatoid arthritis); recovery from acute infections; splenectomy; and certain hematologic conditions including chronic myelomonocytic leukemia and other myelodysplastic syndromes. Medications or stress can sometimes produce mild, transient elevations.

Pathophysiology: Monocytes circulate in blood and migrate into tissues where they differentiate into macrophages and dendritic cells. Monocytosis may reflect increased production in the bone marrow, greater release into circulation, or reduced clearance.

Clinical evaluation: Many patients are asymptomatic and monocytosis is found incidentally. When symptoms occur, they relate to the underlying condition. Evaluation includes a CBC with differential and manual smear, inflammatory markers (ESR/CRP), targeted infectious and autoimmune testing, and imaging as indicated. If monocytosis is persistent, marked, or accompanied by cytopenias, referral to hematology and consideration of bone marrow examination may be indicated.

Management and prognosis: No specific therapy for monocytosis itself; treatment focuses on the underlying cause. Prognosis depends on the underlying disease; transient monocytosis often carries a benign implication.